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Background: 
KardiaMobile is a mobile ECG device, with smartphone connectivity, that is able to detect atrial 
fibrillation (a-fib). The device captures a 30 second reading and an algorithm differentiates a-fib 
from sinus rhythm. The mobile application can alert the user to an a-fib reading and also send 
the ECG output to their personal physician. By monitoring a-fib without accessing traditional 
care, KardiaMobile has the potential to reduce healthcare costs for patients with a-fib. This 
study looked to evaluate the effect of KardiaMobile on healthcare utilization for patients with 
suspected or diagnosed a-fib and who see a clinical cardiac electrophysiologist. 
 
Methods: 
To measure utilization, we conducted a retrospective chart review. A database was created 
documenting the number of times patients went to office visits, the emergency department, were 
admitted to the hospital, had a cardiac procedure done, called/messaged the office, used 
cardiac monitors, and had cardiac imaging conducted. Each of these events were counted for 
one year prior to the first time the patient used KardiaMobile, and up to one year after they 
began using KardiaMobile.  
 
Results: 
Comparing the pre-Kardia and current-Kardia timeframes, we observed a minor overall 
difference in healthcare utilization. Looking at individual points of contact with the healthcare 
system, there was a reduction in emergency department visits. 
 
Conclusion: 
The use of KardiaMobile in patients with diagnosed or suspected a-fib was not associated with 
any difference in overall healthcare utilization. The data show that there was a significant 
reduction in higher acuity points of care--notably emergency department visits.  
